XBRIA Trademark

Trademark Overview

On Monday, October 28, 2013, a trademark application was filed for XBRIA with the United States Patent and Trademark Office. The USPTO has given the XBRIA trademark a serial number of 86103585. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 12, 2017. This trademark is owned by Allergan, Inc.. The XBRIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of migraine and headaches
xbria

General Information

Serial Number86103585
Word MarkXBRIA
Filing DateMonday, October 28, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 12, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2014

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of migraine and headaches

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 4, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllergan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameAllergan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612

Trademark Events

Event DateEvent Description
Monday, June 12, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 12, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, October 16, 2016EXTENSION 5 GRANTED
Monday, September 19, 2016EXTENSION 5 FILED
Monday, September 19, 2016TEAS EXTENSION RECEIVED
Tuesday, March 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 28, 2016EXTENSION 4 GRANTED
Friday, March 18, 2016EXTENSION 4 FILED
Friday, March 18, 2016TEAS EXTENSION RECEIVED
Wednesday, August 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 4, 2015EXTENSION 3 GRANTED
Wednesday, July 22, 2015EXTENSION 3 FILED
Wednesday, July 22, 2015TEAS EXTENSION RECEIVED
Tuesday, May 12, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 11, 2015EXTENSION 2 GRANTED
Tuesday, March 31, 2015EXTENSION 2 FILED
Thursday, May 7, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 31, 2015TEAS EXTENSION RECEIVED
Tuesday, September 9, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 5, 2014EXTENSION 1 GRANTED
Friday, September 5, 2014EXTENSION 1 FILED
Friday, September 5, 2014TEAS EXTENSION RECEIVED
Tuesday, May 6, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 11, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 11, 2014PUBLISHED FOR OPPOSITION
Wednesday, February 19, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 3, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 30, 2014ASSIGNED TO EXAMINER
Monday, November 4, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 31, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

xbria migraine headaches treatment prevention products pharmaceutical